簡介：
TBG Diagnostics Limited, a molecular diagnostics company, researches, develops, manufactures, and markets molecular diagnostics kits, assays, instruments, and services in the United States, Taiwan, and China. The company offers nucleic acid extraction, human leukocyte antigen (HLA) sequence specific primer typing, HLA sequence based typing, and HPA genotyping kits, as well as reagents and accessories, holotype HLA NGS products, and reagents analysis software; equipment comprising nucleic acid extraction, automated pipetting, and gel electrophoresis systems; and HLA genotyping and manufacturing services. It serves clinical labs of hospitals and independent reference labs, blood centers, and bone marrow registry labs. The company was formerly known as Progen Pharmaceuticals Limited and changed its name to TBG Diagnostics Limited in December 2015. TBG Diagnostics Limited was incorporated in 1989 and is based in Greenslopes, Australia.